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Abstract
Objectives-The prognostic significance
ofleukoaraiosis is still not completely elu-
cidated. The objective was to examine
survival and causes of death among
elderly neurological patients with
leukoaraiosis.
Methods-From 1 January 1994, vital sta-
tus and causes of death were drawn from
municipality lists and death certificates of
216 patients (mean age (SD) 70-6 (8.3)
years) admitted to a geriatric unit who
underwent cranial CT between 1 January
1984 and 31 December 1986 (mean obser-
vation period (SD) 8-4 (0.8) years). These
patients had been enrolled for a study of
clinical predictors of leukoaraiosis. Based
on the presence of leukoaraiosis on CT,
this group had been divided into two sub-
groups of patients, with and without
leukoaraiosis. The difference in survival
and causes of death between these groups
formed the objective of the study.
Results-Survival time was shorter
among the 90 patients with leukoaraiosis
than among the 126 patients without
(median survival time 4 07 v 7-78 years,
log rank test P < 0-001). After controlling
for age and other major death predictors,
the risk of death remained significantly
increased (relative risk (RR) = 1-64, 95%
confidence interval (95% CI) 1-15-2-34)
among patients with leukoaraiosis.
Moreover, patients with leukoaraiosis had
an almost threefold higher risk of dying
from vascular causes than patients with-
out (RR = 2-81, 95% CI 1-74-4-53).
Conclusion-Leukoaraiosis is a predictor
of vascular deaths in elderly neurological
patients. Careful diagnostic evaluation
and attention to preventive measures are
required in patients with leukoaraiosis.
(7 Neurol Neurosurg Psychiatry 1997;62: 177-18 1)
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Leukoaraiosis is a term coined to describe
radiological abnormalities seen on brain CT of
elderly patients as bilateral areas of hypoden-
sity in the white matter of the cerebral hemi-
spheres. I
Although the pathogenesis is still incom-
pletely defined, leukoaraiosis has been associ-
ated with various vascular risk factors and
diseases, mainly hypertension, stroke, and
heart disease.2A A vascular pathogenesis of
leukoaraiosis is also suggested by pathological
findings: leukoaraiosis corresponds to areas of
loss of myelin associated with alterations of the
small parenchymal vessels,5 in a region of the
white matter regarded as a border zone.6
Moreover, PET data7 show that the reduction
of cerebral blood flow in areas of leukoaraiosis
is coupled with an increase in oxygen extrac-
tion rate, suggesting an ischaemic condition of
the white matter.
Only recently has attention been drawn to
the possible prognostic importance of
leukoaraiosis. In patients with a history of
cerebrovascular accidents89 or probable
Alzheimer's disease'0 it has been found that
the presence of leukoaraiosis is associated with
an increased risk of subsequent stroke. A study
of our own showed that, in comparison with
neurological controls without leukoaraiosis,
patients with extensive leukoaraiosis and
motor impairment carry an increased risk of
stroke and myocardial infarction."I In this
study leukoaraiosis had no effect on time to
death, but controls without leukoaraiosis had
been deliberately matched with cases for vas-
cular risk factors.
In the present study we sought to examine
whether the presence of leukoaraiosis predicts
death or vascular death irrespective of clinical
presentation or degree of leukoaraiosis. For
this purpose we followed up until death a
cohort of elderly neurological patients who
had been examined between 1984 and 1986
for a study of clinical predictors of leukoaraio-
sis."2 Possible differences in survival and
causes of death (vascular and non-vascular)
between patients with and without leukoaraio-
sis were the object of the present study. The
availability from the original study of an exten-
sive set of data on vascular risk factors, comor-
bid conditions, and clinical characteristics
allowed us to verify whether the potential
prognostic importance of leukoaraiosis regard-
ing death was independent of other death pre-
dictors.
Patients and methods
Detailed information on methods and patients
have been published elsewhere.'2
PATIENTS AND END POINT DEFINITIONS
Study subjects were patients consecutively
admitted for rehabilitation to the geriatric hos-
pital "I Fraticini" (Florence, Italy) who under-
went a cranial CT between 1 January 1984
and 31 December 1986. Activities of this hos-
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Table 1 Demographic characteristics and diagnosis at discharge in the 216 patients
Patients with LA Patients without LA Total
(n = 90) (n = 126) (n = 216)
MJF 44/46 67/59 111/105
Mean age* (SD) (y) 73-7 (6-5) 68-3 (8-8) 70-6 (8-3)
Diagnosis:
Cerebrovascular disease (%) 55-6 46-4 50-2
Non-vascular dementia (%) 22 2 31 2 27-4
Parkinson's disease (%) 5 6 11-2 8-8
Normal pressure hydrocephalus (%) 2-2 3 2 2-8
Other (%) 14-4 8-0 10-8
*At the time of CT.
LA = leukoaraiosis.
Table 2 Risk factors and leukoaraiosis
Leukoaraiosis
Yes (n = 90) No (n = 126) OR (95% CI)
Sex: men 48-9 53-2 0-84 (0-49-1-45)
History of TIA 13 3 12 7 1-06 (0-47-2 36)
History of stroke 38-9 34-1 1-23 (0 70-2 15)
Hypertension 63-3 50 1-73 (0-99-3 00)
Diabetes 13-3 14 3 0-92 (0 42-2 03)
History of heart disease 17 8 18 3 0-97 (0-48-1-96)
Myocardial infarction 5-6 7-1 0-76 (0 25-2 36)
Cardiac arrhythmias 16 7 15-1 1-13 (0 54-2-36)
Left ventricular hypertrophy (ECG) 17 8 11-9 1 60 (0 75-3 43)
Dyslipidaemia 12 2 14-3 0 84 (0-37-1-87)
Proteinuria 34-4 31-7 1-13 (0-64-2-01)
Smoking 25-6 31-0 0-77 (0-42-1 40)
Mean (SD) Mean (SD) P value
Systolic blood pressure (mm Hg) 148 0 (21 6) 146-9 (21-1) 0-697
Diastolic blood pressure (mm Hg) 84-3 (11 1) 86-2 (10-8) 0 211
Blood glucose (mg/dl) 92-9 (30 4) 88-7 (18 4) 0-203
Blood cholesterol (mg/dl) 220-5 (53 5) 229-0 (46-9) 0-170
Blood uric acid (mg/dl) 4-89 (1-29) 5-11 (1-52) 0-259
Blood creatinine (mg/dl) 1-24 (0-41) 1-27 (0 26) 0-600
Packed cell volume (%) 41 6 (4 7) 43-3 (3 9) 0 004
Urine density 1020-3 (3-3) 1019-3 (3-4) 0-035
TIA = Transient ischaemic attack.
Table 3 Neurologicalfeatures and leukoaraiosis
Leukoaraiosis
Yes (%) (n = 90) No (%) (n = 126) Odds ratio (95% CI)
Symptoms:
Motor impairment 47-8 42-1 1-26 (0-73-2-17)
Gait disturbances 38-9 14-3 3-82 (1-98-7-35)*
Sphinter disturbances 15-6 5-6 3-13 (1-21-8-11)*
Vertigo, syncope, seizures 32-2 25-4 1-40 (0-77-2-54)
Dysphagia 7-8 6-3 1-24 (0 43-3 56)
Psychiatric disturbances 50 0 54-0 0-85 (0-50-1-47)
Signs:
Psychiatric abnormalities 7-8 12-7 0-58 (0-23-1 47)
Dysphasia 14-4 17-5 0-80 (0-38-1-68)
Cranial nerve deficits 32-2 37-3 0-80 (0-45-1-41)
Facial deficit 26-7 32-5 0 75 (0-41-1-37)
Gait abnormalities 63-3 41-3 2-46 (1-41-4-29)*
Ataxic 17-8 8-7 2-26 (0-99-5-14)
Paraparesis 11 1 3-2 3-81 (1-16-12-60)*
Parkinson type 8-9 11-9 0-72 (0-29-1-78)
Hemiparetic 26-7 19 8 1-47 (0 77-2 79)
Involuntary movements 11-1 14-3 0 75 (0-33-1-71)
Spasticity 18-9 11-9 1-72 (0-81-3-66)
Increased tendon reflexes 61-1 45-2 1-90 (1-09-3-30)*
Extensor plantar response 34-4 17-5 2-48 (1-32-4-68)*
Cerebellar signs 14-4 6-3 2-49 (0 99-6 29)
Primitive reflexes 40-0 20-6 2-56 (1-40-4-69)*
Palmomental 24-4 8-7 3-28 (1-55-7-40)*
Sucking 26-7 13-5 2-33 (1 17-4-66)*
Glabellar tap 16-7 11-1 1 60 (0-73-3-51)
Dementia 46-7 44-4 1-09 (0-63-1-88)
*Odds ratios significantly different from unity.
Table 4 CTfindings and leukoaraiosis
Leukoaraiosis
pital include neurorehabilitation and geriatric
medicine (each accounting for about half of
the admissions). Most patients with acute or
chronic diseases of the CNS who were admit-
ted to the hospital during the study period
were examined with cranial CT. Out of the
291 patients on whom CT had been per-
formed, 218 patients had CT images suitable
for the study. These 218 patients formed the
cohort who were evaluated clinically in the
previous study'2 and who were considered in
the present follow up study.
Information on vital status and primary
causes of death was achieved by reviewing
municipality death lists and death certificates
looking for those patients who had died
between 1 January 1984 and 31 December
1993. As of 1 January 1994 it was possible to
obtain information on the vital status of 216
out of the 218 patients (mean observation
period (SD) 8-4 (0-8) years). Based on the
radiological assessment, 90 (41 -7%) had
leukoaraiosis and 126 (58-3%) did not. The
two patients (0 9%) who were lost to follow up
belonged to the group with no leukoaraiosis on
CT. Table 1 reports the demographic charac-
teristics and discharge diagnoses in the two
groups. Tables 2-4 show risk factors, neuro-
logical characteristics, and CT data (with fre-
quencies and mean values). Ninety eight of the
216 patients were demented. Types of demen-
tia were distributed as follows: 54 (55- 1%)
with Alzheimer's disease, 36 (36-7%) with vas-
cular dementia, and eight (8 2%) with other
types. Leukoaraiosis was present in 31-5% of
patients with Alzheimer's disease, 58-3% with
vascular dementia, and 50% with other types
of dementia.
From the January 1994 assessment, 131
(60-6%) of the 216 patients were dead and 85
(39-4%) were alive. Two independent referees
(DI and MC), blind to the clinical and radio-
logical characteristics of the patients, exam-
ined death certificate diagnoses to divide
primary causes of death into vascular and non-
vascular. Vascular death comprised death
from stroke, myocardial infarction, and other
vascular deaths. This leukoaraiosis group
encompassed chronic cerebrovascular diseases
(International Classification of Diseases,
Revision 9 (ICD-9),13 code 437), chronic car-
diac diseases (codes 402, 414, 427, 429), and
mixed vascular causes (codes 415, 438, 459).
The agreement between the two observers in
grouping causes of death, as assessed by K sta-
tistics,'4 1' was very good (K = 0-94). In the
four patients in whom they were discordant
agreement was ultimately reached by consen-
sus between the two raters.
CT VARIABLES
All the scans were evaluated by the same
observer (DI) who was blind to the clinical
features and risk factor profile of the patients.
As the evaluation was based only on visual
observation, the definition of the main radio-
logical variables was first validated by an
agreement test between observers measured
by statistics.'4 '5 One neuroradiologist, one
senior neurologist, and one junior neurologist,
Yes (%) No (%.) Odds ratio (95% CI)
Lacunar infarct 24-4 3-2 9-87 (3.26-29-82)*
Non-lacunar infarct 100 31-7 0-24 (0-11-0.52)*
Normal pressure hydrocephalus 2333 71 3096 (1.72-5912)*
Cerebral atrophy58 931f7a08(1d75-5n4l)u
*Odds ratios significantly different from unity.
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blind to the clinical features of the patients,
were asked to evaluate independently from
each other the CT examinations of 30 patients
for defining the CT variables leukoaraiosis,
lacunar infarcts, non-lacunar infarcts, and
cerebral atrophy. The criteria adopted and the
agreement achieved in the definition of each
variable were as follows: (1) leukoaraiosis:
visual identification of patchy or diffuse sym-
metric areas of low attenuation (intermediate
density between that of the normal white mat-
ter and that of intraventricular CSF) with ill
defined margins limited to the periventricular
white matter or extended to the centrum semi-
ovale; the agreement on the assessment of this
finding was substantial (K = 0 67); (2) lacu-
nar infarcts: small (less than 2 cm in diame-
ter), round or oval in shape, sharply
demarcated hypodense areas in the deep cere-
bral matter; the agreement on this item was
moderate (K = 0-51); (3) non-lacunar
infarcts: this category comprised sharply
demarcated, cortically extended, wedge
shaped hypodense areas, with or without local
enlargement of homolateral ventricles and
sulci, subcortical hypodense areas larger than
2 cm in diameter, and watershed infarction;
the agreement on this item was substantial
(K = 0 62); (4) cerebral atrophy, rated into
two categories: (a) no atrophy, including no
atrophy, or atrophy limited to the basal or cor-
tical sulci; (b) atrophy, when both cortical
sulci and lateral ventricles were enlarged; K for
this variable was 0 55. Scans were also
assessed for signs suggestive of normal pres-
sure hydrocephalus as indicated by vas-
silouthis (prominent dilatation of the
unobstructed ventricular system, "rounding"
of frontal horns of lateral ventricles, and oblit-
eration of the cerebral sulci).'6
RISK FACTOR VARIABLES
Categorical variables were the following: (1)
sex; (2) history of transient ischaemic attacks:
focal neurological deficit of less than 24 hours
in duration; (3) history of stroke: focal neuro-
logical deficit of more than 24 hours in dura-
tion; (4) hypertension: previous diagnosis of
hypertension, or history of antihypertensive
treatment, or blood pressure values higher
than 160/95 mm Hg on at least two different
measurements; (5) diabetes, defined according
to the criteria of the National Diabetes Data
Group,'7 including patients with impaired glu-
cose tolerance; (6) history of heart disease,
including history of angina, myocardial infarct,
rhythm disturbances, valvopathies, or ECG
signs of ischaemia or infarct, rhythm distur-
bances, and left ventricular hypertrophy; (7)
myocardial infarction based on history; (8)
cardiac arrhythmias based on history; (9) left
ventricular hypertrophy on ECG; (10) dyslipi-
daemia: previous or current findings of abnor-
mal cholesterol or triglyceride values; ( 11)
previous or intercurrent smoking; (12) pro-
temuna.
Continuous variables were: (1) age; (2) sys-
tolic and diastolic blood pressure; (3) urine
density; (4) packed cell volume; (5) fasting
glucose; (6) total cholesterol; (7) triglycerides;
(8) uric acid; (9) creatinine. Urine density,
together with creatinine and proteinuria, were
studied as indicators of arteriolar nephroscle-
rosis.
CLINICAL FEATURES
Table 3 shows the neurological symptoms and
signs that were assessed. Dementia was
defined according to the DSM-III criteria.'8
The mini mental state examination,'9 the
Blessed dementia scale, and the Wechsler
adult intelligence scale2' were used as mea-
sures of cognitive functions. Functional status
was assessed with the activities of daily living
scale of Katz et al.22 Information on social
fumctioning was collected in a non-structured
fashion by the nurses and social workers of the
geriatric team.
STATISTICAL ANALYSIS
Because of the large age difference between
the two groups of patients with and without
leukoaraiosis, the effect of leukoaraiosis in pre-
dicting death had to be controlled for age.
Besides age, there were other risk factors and
comorbid conditions known to be associated
with both age and leukoaraiosis that could
influence the prediction of death among
patients with leukoaraiosis. To verify whether
leukoaraiosis had an independent effect on
death we used Cox's regression analysis.2'
Among baseline variables as important predic-
tors of death in our sample, we selected sex,
previous stroke, hypertension, diabetes, heart
disease, and dementia. For each of the three
end points (all deaths, death from stroke, and
death from vascular causes) leukoaraiosis was
examined as a predictive variable together with
age and the other covariate variables by means
of three separate Cox regression models. The
results were expressed as relative risk (RR)
with 95% confidence intervals (95% CIs).24
Table 5 Causes ofdeath in patients with and without leukoariosis
Patients with LA Patients without LA Total
(n = 90) (n = 126) (n =216)
Total deaths 66 (73-3%) 65 (51-6%) 131 (60 6%)
Stroke (ICD codes 430-4) 16 (17-8%) 16 (12-7%) 32 (14-8%)
Myocardial infarction (ICD code 410) 2 (2 2%) 4 (3-2%) 6 (2-8%)
Other vascular deaths 31 (34 4%) 11 (8-7%) 42 (19-4%)
Chronic or less defined cerebrovascular
diseases (ICD code 437) 18 (20 0%) 8 (6-3%) 26 (12-0%)
Chronic or less defined cardiac diseases
(ICD codes 414, 402, 427, 429) 8 (8-9%) 3 (2-4%) 11 (5-1%)
Others (ICD codes 415, 438, 453, 459) 5 (5 5%) 0 (-) 5 (2-3%)
Non-vascular causes 15 (16-7%) 34 (27%) 49 (22-7%)
Unknown 2 (2-2%) - 2 (0-9%)
LA = leukoariosis.
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Table 6 Prediction of death from any cause, vascular, and stoke death (Cox proportional
hazard models) by leukoaraiosis and other potential predictors of death
RR (95% CIs)
Vanrables Total death Vascular death Stoke death
Leukoaraiosis 1-68 (1-18-2-39)* 2-85 (1 76-4 59)* 1 89 (0-88-4 07)
Aget 1-36 (1 19-1 55)* 1 41 (1 18-1-69)* 1 34 (1-03-1-75)*
Male sex 1-46 (1-02-2-10)* 1-77 (1-10-2-83)* 1-89 (0-89-4 04)
Previous stroke 1-63 (1-08-2-47)* 1-76 (1-04-2-99)* 2-31 (0-98-5-43)
Hypertension 1-54 (1-08-2-21)* 1-96 (1-24-3-11)* 1-87 (0 90-3 88)
Diabetes 1-08 (0-63-1-83) 1-67 (0-91-3 04) 3-10 (1-38-6-97)*
Heart disease 2-07 (1-32-3-26)* 2-58 (1-46-4-56)* 3 02 (1-33-6-88)*
Dementia 2-42 (1-66-3-54)* 2-54 (1-56-4-14)* 1-23 (0 56-2 69)
*Odds ratio significantly different from unity.
tRisk per five year age group.
When analysing each specific cause of death,
patients who died from other causes were con-
sidered as censored data. Moreover, we sought
to determine whether among all the baseline
variables (risk factors and clinical or radiologi-
cal features) we had available in our database,
there were other possible confounders or mod-
ifiers. We used a forward stepwise method to
examine leukoaraiosis together with this larger
set of variables in relation to death and specific
causes of death grouped as indicated above.
Results
The proportion of deceased patients in each
group was 66/90 in the leukoaraiosis group
and 65/126 in the non-leukoaraiosis group.
The median survival time was shorter among
patients with than among those without
leukoaraiosis (4 07 years v 7-78 years; log-rank
test P < 0 001).
Table 5 shows the deaths and causes of
death in the total cohort and in the two groups
of patients with and without leukoaraiosis. In
two of the 131 patients who died it was not
possible to define the cause of death because
death certificates were missing. Both these
patients showed leukoaraiosis on CT. The
number and percentages of patients who died
from any cause, from stroke, or from other
vascular causes were all higher among the
leukoaraiosis than the non-leukoaraiosis group
(table 5). Among patients who died from vas-
cular causes, 32 died from stroke, six from
myocardial infarction, and 42 from other vas-
cular causes. The last group included mainly
deaths from chronic cerebrovascular or car-
diac diseases. Deaths from myocardial infarc-
tion occurred infrequently, with no substantial
difference, in either group.
After controlling for age and other major
predictors of death, patients with leukoaraiosis
had a 1 5-fold higher death risk, and an almost
threefold (RR = 2-80, 95% CI 1-74-4-53)
higher risk of dying from a vascular cause than
patients without leukoaraiosis (table 6). Both
these risk increases were significant. The risk
of dying from stroke was also increased among
patients with leukoaraiosis but the difference
was not significant. Table 6 gives information
on significance of the other major predictors of
death.
To examine the weight of chronic cere-
brovascular diseases (ICD-9 code 437; a con-
dition in which leukoaraiosis is supposedly
frequent) in predicting vascular death, we car-
ried out the same analysis excluding the
patients deceased from this cause (treated as
censored data in the Cox model). The relative
risk of vascular death remained substantially
unchanged (RR = 2-62, 95% CI 1-45-4-72).
For the analyses carried out with
leukoaraiosis and the larger set of baseline
variables, leukoaraiosis again turned out to be a
significant independent predictor of death
from any cause (RR= 1-45, 95% CI
1-01-2-09). Other independent predictors
were age, myocardial infarction, motor distur-
bances, cognitive impairment, blood creati-
nine, and CT showing normal pressure
hydrocephalus. Considering stroke death,
leukoaraiosis showed a positive but not signifi-
cant predictive effect (RR = 1-27, 95% CI
0-62-2-57); the significant predictors were
age, motor disturbances, and creatinine val-
ues. For vascular death, leukoaraiosis had a
significant predictive effect (RR = 2 78, 95%
CI 1 72-4 50), together with age, cardiac dis-
ease, motor disturbances, cognitive impair-
ment, and creatinine values.
Discussion
Our results indicate that leukoaraiosis predicts
vascular death in elderly neurological patients.
This seems independent of age and other risk
factors and comorbid conditions (including
previous stroke) known to be associated with
leukoaraiosis. The association with death from
stroke alone is less striking.
By contrast with previous outcome stud-
ies,'911 we examined a less specific group of
patients with leukoaraiosis. In fact, our study
sample consisted of patients with various neu-
rological diseases, although half of them had
cerebrovascular disease. Moreover, we
included patients with any degree of
leukoaraiosis. This might explain some differ-
ences from previous studies8 '" which had
shown an increased risk of stroke or death
from stroke.
The cause of death in patients with
leukoaraiosis was the object of a recently pub-
lished study that had been carried out in
Finland.29 Similarly to ours, this study exam-
ined patients admitted to a geriatric depart-
ment. Different from our study, it was
retrospective, and did not consider the possi-
ble confounding effect of risk factors.
However, the conclusion that leukoaraiosis
was more strictly associated with death from
cardiovascular causes than death from stroke
is consistent with our finding.
The results of our study have to be regarded
with some caution. The causes of death were
based on death certificate diagnoses. The relia-
bility of this type of diagnosis is questioned.
Studies of validity of diagnoses from death cer-
tificates have been conducted in Italy within
the "Seven Countries Study": sensitivity and
specificity values were over 70% and 90% for
the diagnoses of death from myocardial infarc-
tion and from stroke respectively.2", The diag-
noses of chronic or less defined cardiovascular
diseases are presumably less reliable.
However, in our study, possible inaccuracies
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in death diagnoses should have affected the
two groups of patients equally.
The conclusion drawn from our findings
may be limited by a few factors. The study
population was a subsample of all the neuro-
logical patients admitted to our geriatric hos-
pital during the study period. In the preceding
paper on these patients,'2 we discussed the
selection bias related to the exclusion of some
patients because CT had not been performed
or had yielded poor quality images. After
examining the characteristics of these patients,
we found that they were not different from the
included patients according to demographic
data and risk factors. Most of the excluded
patients were those who were uncooperative in
the CT examination, and therefore were pre-
sumably more severely demented than the
included ones. We have no further way to
judge whether and in which way this selection
could have affected our conclusions. Although
in that period "I Fraticini" Hospital admitted
the vast majority of elderly neurological
patients requiring rehabilitation in our area,
we cannot be sure that these patients were rep-
resentative of all elderly neurological patients
occurring in the population.
Despite these shortcomings, we think that
our study is of value for the following reasons:
(1) data on the prognostic importance of
leukoaraiosis were scanty; (2) the patients
were studied prospectively; (3) we had a group
of patients without leukoaraiosis as controls;
(4) we had a large set of baseline information
on risk factors and comorbid conditions to be
studied as covariates in relation to the predic-
tion of death.
Our results suggest that leukoaraiosis can be
regarded as a marker of cardiovascular disease.
This is in agreement with other clinicopatho-
logical and laboratory findings indicating an
ischaemic origin of these radiological appear-
ances in patients with multiple vascular risk
factors and several associated cardiovascular
abnormalities.7 Consequently, elderly patients
presenting with neurological problems and
leukoaraiosis on CT should be investigated for
cardiovascular abnormalities and given appro-
priate treatment.
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